Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bruker (BRKR) Invested Capital (2016 - 2026)

Bruker filings provide 17 years of Invested Capital readings, the most recent being $2.5 billion for Q4 2025.

  • On a quarterly basis, Invested Capital rose 37.29% to $2.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.5 billion, a 37.29% increase, with the full-year FY2025 number at $2.5 billion, up 37.29% from a year prior.
  • Invested Capital hit $2.5 billion in Q4 2025 for Bruker, up from $2.5 billion in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $2.5 billion in Q4 2025 to a low of $965.0 million in Q3 2022.
  • Median Invested Capital over the past 5 years was $1.8 billion (2021), compared with a mean of $1.7 billion.
  • Biggest five-year swings in Invested Capital: tumbled 53.42% in 2022 and later surged 39.7% in 2023.
  • Bruker's Invested Capital stood at $2.4 billion in 2021, then tumbled by 53.42% to $1.1 billion in 2022, then soared by 34.55% to $1.5 billion in 2023, then rose by 19.65% to $1.8 billion in 2024, then skyrocketed by 37.29% to $2.5 billion in 2025.
  • The last three reported values for Invested Capital were $2.5 billion (Q4 2025), $2.5 billion (Q3 2025), and $1.9 billion (Q2 2025) per Business Quant data.